Leap Therapeutics Inc (NASDAQ: LPTX) Is Currently -38.89 Percent Below Its 52-Week High, But It Still Offers Strong Upside Potential.
Leap Therapeutics Inc (NASDAQ:LPTX)’s traded shares stood at 1.51 million during the last session, with the company’s beta value hitting 0.27. At the close of